Silicon Valley's default response to crazy ideas is curiosity, not cynicism, which fosters greater ambition. Crucially, the culture values the experience gained from failure. A founder who raised and lost $50 million is still seen as a valuable bet by investors, a dynamic not found in other ecosystems.

A cultural divide exists in biotech investing. East Coast VCs, rooted in a traditional biotech ecosystem, are more skeptical of AI and demand hard biological data. West Coast VCs, surrounded by tech innovation, are more comfortable backing the promise of AI platforms before seeing extensive wet lab validation.

Redpoint Ventures' Erica Brescia describes a shift in their investment thesis for the AI era. They are now more likely to back young, "high-velocity" founders who "run through walls to win" over those with traditional domain expertise. Sheer speed, storytelling, and determination are becoming more critical selection criteria.

Founder Fred Turner notes a key cultural difference: UK investors focus on credentials and mitigating worst-case scenarios, asking 'how do I not get fired?'. In contrast, Silicon Valley investors focus on the maximum possible outcome, asking 'how big could this be in ten years?', making them more open to young, unproven founders.

A key cultural difference in venture capital is that European VCs often request late-stage metrics like five-year financial projections from pre-seed companies. This contrasts sharply with the US/SF focus on market size, team, and vision at the earliest stages of a company's life.

Investor Moritz Baier-Lentz focuses on founders pursuing "global optima"—audacious, industry-defining goals. He actively avoids incremental ideas or teams that tout their "veteran" experience. The key traits he looks for are first-principles thinking and an obsession with solving a problem no one else is.

Bug Crowd's founder learned his Australian VC pitch, focused on predictable ROI (a "sausage machine"), fell flat in the US. American VCs wanted a massive, category-creating vision. He had to reframe his pitch from a "better pen test" to a fundamental shift in the "future of work" for cybersecurity to succeed.

When fundraising, pitch the creation of a new market category, not just a better product. Investors view incremental improvements as capped opportunities fighting for existing market share. They disproportionately fund 'different' companies that can create, own, and dominate an entirely new market space.

When evaluating revolutionary ideas, traditional Total Addressable Market (TAM) analysis is useless. VCs should instead bet on founders with a "world-bending vision" capable of inducing a new market, not just capturing an existing one. Have the humility to admit you can't predict market size and instead back the visionary founder.